首页> 外文期刊>Powder Technology: An International Journal on the Science and Technology of Wet and Dry Particulate Systems >Process analytical technology applied for end-point detection of pharmaceutical blending by combining two calibration-free methods: Simultaneously monitoring specific near-infrared peak intensity and moving block standard deviation
【24h】

Process analytical technology applied for end-point detection of pharmaceutical blending by combining two calibration-free methods: Simultaneously monitoring specific near-infrared peak intensity and moving block standard deviation

机译:结合两种免校准方法,将过程分析技术应用于药物混合的终点检测:同时监控特定的近红外峰强度和移动块标准偏差

获取原文
获取原文并翻译 | 示例
           

摘要

Here, we describe a combination approach using Two Calibration-Free Methods with reflectance near-infrared (TCFM-NIR), which involves detecting end-points for active pharmaceutical ingredients (APIs) blending by simultaneously monitoring specific N1R peak intensity of APIs and calculating moving block standard deviation (MBSD). After determining the specific N1R peak range of nicaldipine hydrochloride, conditions for TCFM-NIR were established by monitoring the differential intensity of the second peak (1136 nm) while MBSD was calculated from the NIR peak intensity between 1100 and 1150 nm. In comparison with the validated reference method of UV-VIS spectroscopy, which is particularly destructive, TCFM-NIR was found to be useful in detecting end-points for blending of nicaldipine hydrochloride. TCFM-NIR monitors two important factors for estimation of blend uniformity: API concentration, using specific NIR peak intensity for APIs, and blend homogeneity, using MBSD. Also, the conditions of TCFM-NIR were confirmed to be adequate by using Partial Least Square (PLS). Further, simultaneously monitoring these two blend uniformity factors is more useful in preventing estimation errors for nondestructive monitoring of blend homogeneity than monitoring only one factor, as with NIR spectroscopy.
机译:在这里,我们描述了一种使用两种免校准方法和反射率近红外(TCFM-NIR)的组合方法,该方法涉及通过同时监控API的特定N1R峰强度并计算移动量来检测活性药物成分(API)混合的终点块标准偏差(MBSD)。在确定了盐酸尼卡地平的特定N1R峰范围后,通过监测第二个峰(1136 nm)的微分强度来建立TCFM-NIR的条件,而MBSD是根据1100和1150 nm之间的NIR峰强度计算得出的。与经过验证的特别具有破坏性的UV-VIS光谱参考方法相比,TCFM-NIR可用于检测盐酸尼卡地平的掺混终点。 TCFM-NIR监测两个重要因素来评估共混物的均匀度:API浓度(使用API​​的特定NIR峰强度)和共混物均匀性(使用MBSD)。另外,通过使用偏最小二乘(PLS)可以确定TCFM-NIR的条件是适当的。此外,与NIR光谱法一样,与仅监视一个因素相比,同时监视这两个共混物均匀性因子对于防止共混物均匀性的非破坏性监视而言,对于防止估计误差更为有用。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号